Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Shares Issued (2022 - 2025)

Praxis Precision Medicines (PRAX) has 4 years of Shares Issued data on record, last reported at $11.6 million in Q4 2025.

  • For Q4 2025, Shares Issued rose 488.25% year-over-year to $11.6 million; the TTM value through Dec 2025 reached $13.3 million, up 404.14%, while the annual FY2025 figure was $13.3 million, 404.14% up from the prior year.
  • Shares Issued reached $11.6 million in Q4 2025 per PRAX's latest filing, up from $808000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $11.6 million in Q4 2025 and bottomed at $1000.0 in Q3 2023.
  • Average Shares Issued over 4 years is $1.1 million, with a median of $304500.0 recorded in 2024.
  • Peak YoY movement for Shares Issued: crashed 99.76% in 2023, then skyrocketed 20000.0% in 2024.
  • A 4-year view of Shares Issued shows it stood at $163000.0 in 2022, then plummeted by 34.97% to $106000.0 in 2023, then surged by 1762.26% to $2.0 million in 2024, then skyrocketed by 488.25% to $11.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $11.6 million in Q4 2025, $808000.0 in Q3 2025, and $294000.0 in Q2 2025.